selumetinib Report issue

Small molecule Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Selumetinib (INN), sold under the brand name Koselugo, is a medication for the treatment of children, two years of age and older, with neurofibromatosis type I (NF-1), a genetic disorder of the nervous system causing tumors to grow on nerves. It is taken by mouth.   Wikipedia

  • SMILES: Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO.OS(=O)(=O)O
  • InChIKey: GRKFGZYYYYISDX-UHFFFAOYSA-N
  • Mol. Mass: 555.77
  • ALogP: 3.53
  • ChEMBL Molecules:
More Chemistry

Drug Pricing (per unit)

United States

$55.1687 - $181.4760
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

arry142886 | arry 142886 | arry-142886 | arry-886 | az6244 | azd6244 | azd 6244 | azd-6244 | seleumetinib | selumetinib | selumetinib sulfate

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue